Compare Stocks

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

The Beacon Selective Risk ETF (BSR) is an exchange-traded fund that mostly invests in target outcome asset allocation. The fund is an active fund-of-funds, specifically from Vanguard, seeking capital appreciation by investing in US equities while attempting to minimize losses in volatile markets. The fund utilizes a potential risk mitigation strategy to exit specific sectors into fixed-income securities. BSR was launched on Apr 17, 2023 and is managed by Sammons Enterprises.

EMX Royalty Corporation, together with its subsidiaries, explores for and generates royalties from metals and minerals properties. It explores gold, silver, platinum, palladium, copper, lead, zinc, manganese, nickel, cobalt, molybdenum, and iron deposits. The company's royalty and exploration portfolio primarily consist of properties in North America, Türkiye, Europe, Australia, Latin America, Morocco, and Australia. The company was formerly known as Eurasian Minerals Inc. and changed its name to EMX Royalty Corporation in July 2017. EMX Royalty Corporation is headquartered in Vancouver, Canada.

First Trust Value Line 100 Exchange-Traded Fund (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Value Line 100 Index (the Index). The Index is an equal-dollar weighted index that is designed to objectively identify and select 100 stocks from the universe of stocks, to which Value Line assigns a #1 ranking in the Value Line Timeliness Ranking System (the Ranking System). At any one time, only 100 stocks are assigned a #1 ranking in the Ranking System. The Index is rebalanced quarterly. The Fund will normally invest at least 90% of its assets in common stocks that comprise the Index. The Fund's investment advisor is First Trust Advisors L.P.

Abitibi Royalties Inc. engages in exploring, evaluating, and promoting mineral properties and other projects in Canada. Its flagship royalty is 3% net smelter return royalty located on the eastern portion of the Canadian Malartic mine that includes the East Malartic, Odyssey, Sladen, Sheehan, Jeffrey, Barnat Extension, Gouldie Zone, and the Charlie Zone. The company was incorporated in 2010 and is headquartered in Val-d'Or, Canada.